We are live on
!
Find out more
Los Angeles Capital Management Portfolio holdings
AUM
$25.4B
1-Year Est. Return
38.46%
This Fund
S&P 500
This Quarter
Est. Return
-3.12%
1 Year Est. Return
+38.46%
3 Year Est. Return
+154.38%
5 Year Est. Return
+223.79%
10 Year Est. Return
+923.25%
AUM
$19.3B
AUM Growth
-$1.05B
(-5.2%)
Cap. Flow
-$77.1M
Cap. Flow
% of AUM
-0.4%
Top 10 Holdings %
Top 10 Hldgs %
26.03%
Holding
1,444
New
138
Increased
405
Reduced
531
Closed
234
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$224M |
| 2 |
Brown-Forman Class B
BF.B
|
+$140M |
| 3 |
UnitedHealth
UNH
|
+$132M |
| 4 |
Monolithic Power Systems
MPWR
|
+$108M |
| 5 |
Oracle
ORCL
|
+$97.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$134M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$122M |
| 3 |
Micron Technology
MU
|
+$122M |
| 4 |
Pfizer
PFE
|
+$120M |
| 5 |
Microsoft
MSFT
|
+$117M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.43% |
| 2 | Healthcare | 14.49% |
| 3 | Financials | 11.62% |
| 4 | Consumer Discretionary | 10.92% |
| 5 | Industrials | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Marvell Technology
MRVL
$195B
| $5.41M | 0.03% |
126,085
-15,275
| -11% | -$756K |
|
352
Crown Castle
CCI
$31.5B
| $5.37M | 0.03% |
37,180
-144,146
| -79% | -$24.7M |
|
353
NextEra Energy
NEE
$179B
| $5.37M | 0.03% |
68,479
+37,359
| +120% | +$3.17M |
|
354
Equinix
EQIX
$105B
| $5.36M | 0.03% |
9,416
+7,623
| +425% | +$4.98M |
|
355
Erie Indemnity
ERIE
$13.5B
| $5.29M | 0.03% |
23,801
-381
| -2% | -$80.2K |
|
356
BJs Wholesale Club
BJ
$11.8B
| $5.27M | 0.03% |
+72,432
| New | +$5.19M |
|
357
Prologis
PLD
$134B
| $5.27M | 0.03% |
51,882
+2,590
| +5% | +$321K |
|
358
American Water Works
AWK
$26.8B
| $5.22M | 0.03% |
40,102
+33,154
| +477% | +$4.99M |
|
359
EPAM Systems
EPAM
$5.17B
| $5.18M | 0.03% |
14,305
-1,523
| -10% | -$583K |
|
360
Dominion Energy
D
$59.8B
| $5.17M | 0.03% |
74,849
+6,780
| +10% | +$547K |
|
361
PACCAR
PCAR
$69B
| $5.16M | 0.03% |
92,442
+82,743
| +853% | +$4.81M |
|
362
Saia
SAIA
$9.73B
| $5.12M | 0.03% |
26,948
-1,200
| -4% | -$254K |
|
363
Lamar Advertising Co
LAMR
$15.6B
| $5.02M | 0.03% |
60,817
+225
| +0.4% | +$21.4K |
|
364
First Financial Bankshares
FFIN
$5.01B
| $4.99M | 0.03% |
119,387
+72,301
| +154% | +$3.11M |
|
365
Danaher
DHR
$145B
| $4.91M | 0.03% |
21,448
-11,739
| -35% | -$2.87M |
|
366
Bio-Techne
TECH
$11.3B
| $4.88M | 0.03% |
68,672
+21,348
| +45% | +$1.84M |
|
367
Organon & Co
OGN
$3.59B
| $4.83M | 0.03% |
206,567
-86,662
| -30% | -$2.62M |
|
368
International Paper
IP
$21.8B
| $4.81M | 0.02% |
151,681
-180,664
| -54% | -$7.38M |
|
369
Fox Class A
FOXA
$26.5B
| $4.69M | 0.02% |
152,918
-156,678
| -51% | -$5.3M |
|
370
iShares Core MSCI Emerging Markets ETF
IEMG
$158B
| $4.69M | 0.02% |
109,112
+4,812
| +5% | +$231K |
|
371
Columbia Sportswear
COLM
$2.88B
| $4.64M | 0.02% |
69,002
-334,883
| -83% | -$24.5M |
|
372
Vistra
VST
$49.2B
| $4.61M | 0.02% |
219,513
+199,548
| +999% | +$4.83M |
|
373
Healthcare Realty
HR
$6.58B
| $4.61M | 0.02% |
220,960
+212,881
| +2,635% | +$5.41M |
|
374
Zscaler
ZS
$28.7B
| $4.57M | 0.02% |
27,827
+21,377
| +331% | +$3.5M |
|
375
Chemed
CHE
$7.07B
| $4.54M | 0.02% |
10,397
-1,109
| -10% | -$533K |
|
Similar funds
VAI
Los Angeles Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, Los Angeles Capital Management held 1,444 positions worth $19.3B, down 5.2% from $20.3B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Los Angeles Capital Management's Q3 2022 filing shows 138 new, 405 increased, 531 reduced and 234 closed positions. Its largest new stake was Neurocrine Biosciences: 791,966 shares worth $84.1M. The largest sale was Alphabet (Google) Class C, an estimated $134M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
- Los Angeles Capital Management's largest Q3 2022 buy was Neurocrine Biosciences: 791,966 shares worth $84.1M.
- Los Angeles Capital Management added most to Broadcom in Q3 2022, an estimated $224M increase.
- Los Angeles Capital Management's biggest Q3 2022 reduction was Alphabet (Google) Class C, cutting an estimated $134M.
- Los Angeles Capital Management fully exited D.R. Horton in Q3 2022, selling an estimated $37.1M.
- Los Angeles Capital Management's ten largest holdings make up 26% of its $19.3B portfolio in Q3 2022.
- Los Angeles Capital Management opened 138 new positions and closed 234 in Q3 2022.
- Los Angeles Capital Management's portfolio value fell 5.2% quarter-over-quarter to $19.3B.
Based on Los Angeles Capital Management's 13F filing for Q3 2022, filed 2 Nov 2022.